Brian Calvey is a partner in the firm's Stamford office. He focuses his practice on corporate finance, securities (1933 Act and 1934 Act issues), mergers and acquisitions, joint ventures and strategic alliances, private equity, executive compensation and a wide range of commercial contracts (distribution, sales agency, supply, manufacturing and similar agreements).

Brian has represented clients involved in the telecommunications, publishing, pharmaceuticals (ethical and over-the-counter), alcoholic beverage, household products, chemicals, soft drink, electronics and other industries.

Represented GrafTech International Ltd. in connection with a private placement of $300 million of senior notes and a later registered exchange offer of registered notes for the privately placed notes.

Represented GrafTech International Ltd. in connection with its acquisition of Seadrift Coke L.P. and C/G Electrodes LLC.

Represented the largest provider of information technology and business process outsourcing services in India in connection with its acquisition of Citigroup Global Services Limited from Citigroup Inc.

Represented a leading German pharmaceutical company in connection with a structured buyout of Actimis Pharmaceuticals, Inc.

Represented Dictaphone Corporation in connection with its merger into a subsidiary of Nuance Communications, Inc.

Represented Dictaphone Corporation in connection with the sale of assets of its Electronic Manufacturing Services Division to Bulova Technologies, L.L.C.

Represented Transervice Lease Corp. in connection with the sale of assets of its Transervice Trailer Rental and Leasing Division to Vanguard Modular Building Systems, LLC.

Represented certain affiliated investment vehicles of MidOcean Partners and CSFB Private Equity, Inc. in connection with their acquisition of the assets of Thompson Publishing Group, Inc.

Represented certain affiliated investment vehicles of multiple leading private equity firms in connection with a recapitalization of a specialized behavioral health care services company.

Represented certain affiliated investment vehicles of multiple leading private equity firms in connection with the acquisition by a specialized behavioral health care services company of the stock of National Specialty Clinics, Inc.

Represented a direct access broker-dealer in connection with its acquisition by BNY ESI & Co., Inc. and The Bank of New York.

Represented a New York Stock Exchange specialist firm in connection with its merger into a subsidiary of The Goldman Sachs Group, Inc.

Represented a New York Stock Exchange specialist firm in connection with its acquisition by Mill Bridge IV, LLC and Van der Moolen Specialists USA, LLC.

Represented a Netherlands aircraft finance company in connection with a private placement of $125 million of senior notes in the United States.

Represented a competitive local exchange carrier in connection with a Rule 144A offering of $275 million of senior notes and a later-registered exchange offer of those notes for registered notes.

Represented Standard Motor Products, Inc., a manufacturer of replacement parts for automobiles, in connection with a registered offering of $90 million of convertible subordinated debentures.

Represented a competitive local exchange carrier in connection with a private placement of $100 million of PIK preferred stock.

Represented a competitive local exchange carrier in connection with a Rule 144A offering of $460 million principal amount at maturity of senior discount notes and a later-registered exchange offer of those notes for registered notes.

Represented The Reader's Digest Association, Inc. in connection with its acquisition of Walking Magazine from Cowles Media Company.

Represented The Reader's Digest Association, Inc. in connection with its disposition of Travel Holiday Magazine and The National Travel Club to Hachette Filipacchi Magazines, Inc.

Represented The Reader's Digest Association, Inc. in connection with a joint venture with Meredith Corporation.

Represented a global pharmaceutical company in connection with the disposition of certain rights with respect to its pHisoDerm product line to Chattem, Inc., a Chattanooga, Tennessee, producer of over-the-counter pharmaceuticals.

Represented a global pharmaceutical company in connection with a joint venture with Elf Sanofi, a French pharmaceuticals company, covering the sale of over-the-counter pharmaceutical products in certain countries of Central and Eastern Europe.

Represented a global pharmaceutical company in connection with the negotiation of a ground lease, environmental matters agreement, and related documents in connection with the acquisition by a new purchaser (from a former purchaser of our client) of certain assets of the client's former Hilton-Davis Chemical Co. business.

Represented a global pharmaceutical company in connection with the establishment of a joint venture with Elf Sanofi covering the sale of ethical and over-the-counter pharmaceutical products in Mexico and Brazil.

Represented a well-known rum and spirits company in connection with its acquisition of a 50 percent equity interest in a packaging company.

Represented a global pharmaceutical company in connection with the establishment of its strategic alliance with Elf Sanofi covering the sale of ethical and over-the-counter pharmaceutical products, which resulted in the establishment of a series of joint ventures with aggregate annual sales approaching $4 billion. The work included the establishment of joint ventures in the United States, France and a number of Western European countries.